Importantly, TRPV1 has also been identified as the regulated molecular component of the atrial natriuretic signaling pathway and as a potential molecular target in HF and cardiac hypertrophy induced by TAC in mice. This evidence concerns the gene TRPV1 and cardiac hypertrophy.